US Bancorp’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$989 Buy
+259
New +$1.25K ﹤0.01% 3980
2026
Q1
Sell
-46
Closed -$355 4347
2025
Q4
$355 Buy
+46
New +$410 ﹤0.01% 3945
2025
Q3
Sell
-23
Closed -$95 4302
2025
Q2
$95 Hold
23
﹤0.01% 4114
2025
Q1
$139 Buy
+23
New +$141 ﹤0.01% 4124
2020
Q3
Sell
-583
Closed -$12K 3859
2020
Q2
$12K Buy
583
+416
+249% +$11K ﹤0.01% 3049
2020
Q1
$5K Buy
167
+84
+101% +$2.11K ﹤0.01% 3281
2019
Q4
$1K Buy
+83
New +$1.19K ﹤0.01% 3601

Other funds holding VSTM

US Bancorp's VSTM Position: Q2 2026 in Review

US Bancorp opened a new position in Verastem (VSTM) in Q2 2026: 259 shares worth $989. The stake represents ﹤0.01% of the portfolio and ranks #3980 among its holdings. This is a return to the name: US Bancorp previously reported a position in VSTM as recently as Q4 2025.

US Bancorp first reported a position in VSTM in Q4 2019 and has held it in 7 quarters since. The position peaked at $12K in Q2 2020. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • US Bancorp held 259 shares of Verastem worth $989 as of Q2 2026.
  • Verastem was a new US Bancorp position in Q2 2026.
  • Verastem made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3980 holding.
  • US Bancorp first reported a position in Verastem in Q4 2019 and has held it in 7 quarters since.
  • US Bancorp's Verastem position peaked at $12K in Q2 2020.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.